Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Assembly Biosciences
(NQ:
ASMB
)
14.61
+0.20 (+1.39%)
Streaming Delayed Price
Updated: 3:49 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
20,829
Open
14.60
Bid (Size)
14.61 (1)
Ask (Size)
14.85 (1)
Prev. Close
14.41
Today's Range
14.33 - 14.99
52wk Range
7.692 - 20.04
Shares Outstanding
52,121,309
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
ASMB Stock Earnings: Assembly Biosciences Beats EPS, Beats Revenue for Q2 2024
August 09, 2024
ASMB stock results show that Assembly Biosciences beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Assembly Biosciences Reports Second Quarter 2024 Financial Results and Recent Updates
August 08, 2024
From
Assembly Biosciences, Inc.
Via
GlobeNewswire
Performance
YTD
+46.33%
+46.33%
1 Month
-1.55%
-1.55%
3 Month
-3.05%
-3.05%
6 Month
+26.17%
+26.17%
1 Year
+36.38%
+36.38%
More News
Read More
Assembly Biosciences Presents New Preclinical Data Highlighting Investigational Helicase-Primase Inhibitors at International Herpesvirus Workshop
July 15, 2024
From
Assembly Biosciences, Inc.
Via
GlobeNewswire
Insiders Buying American Software And 2 Other Stocks
July 09, 2024
Via
Benzinga
Assembly Biosciences Doses First Participant in Phase 1b Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 for the Treatment of Chronic Hepatitis B Virus Infection
June 18, 2024
From
Assembly Biosciences, Inc.
Via
GlobeNewswire
Assembly Biosciences Announces $12.6 Million in Equity Financings
June 17, 2024
From
Assembly Biosciences, Inc.
Via
GlobeNewswire
Assembly Biosciences Doses First Participant in Phase 1a/b Clinical Trial of Herpes Simplex Virus Helicase-Primase Inhibitor Candidate ABI-5366
June 10, 2024
From
Assembly Biosciences, Inc.
Via
GlobeNewswire
Assembly Biosciences Presents New Data Highlighting Hepatitis D Virus Entry Inhibitor ABI-6250 at the EASL Congress™ 2024
June 05, 2024
From
Assembly Biosciences, Inc.
Via
GlobeNewswire
Assembly Biosciences to Present Data at Upcoming International Herpesvirus Workshop and EASL Congress™ 2024
May 22, 2024
From
Assembly Biosciences, Inc.
Via
GlobeNewswire
ASMB Stock Earnings: Assembly Biosciences Beats EPS for Q1 2024
May 13, 2024
Via
InvestorPlace
Assembly Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights
May 08, 2024
From
Assembly Biosciences, Inc.
Via
GlobeNewswire
ASMB Stock Earnings: Assembly Biosciences Beats EPS for Q4 2023
March 28, 2024
Via
InvestorPlace
Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights
March 28, 2024
From
Assembly Biosciences, Inc.
Via
GlobeNewswire
ASMB Stock Earnings: Assembly Biosciences Misses EPS for Q2 2023
March 25, 2024
Via
InvestorPlace
Assembly Biosciences Announces Effective Date of Reverse Stock Split
February 08, 2024
From
Assembly Biosciences, Inc.
Via
GlobeNewswire
Assembly Biosciences Provides Anticipated Development Milestones for 2024
January 04, 2024
From
Assembly Biosciences, Inc.
Via
GlobeNewswire
Why Icosavax Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
December 12, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 24, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
November 23, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 22, 2023
Via
Benzinga
Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 10, 2023
From
Assembly Biosciences, Inc.
Via
GlobeNewswire
Assembly Biosciences Presents New Data Highlighting Viral Hepatitis Portfolio at AASLD The Liver Meeting®
November 10, 2023
From
Assembly Biosciences, Inc.
Via
GlobeNewswire
Assembly Biosciences Reports Third Quarter 2023 Financial Results and Recent Updates
November 08, 2023
From
Assembly Biosciences, Inc.
Via
GlobeNewswire
Assembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief Medical Officer
November 08, 2023
From
Assembly Biosciences, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 25, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.